Our Board

Vision, Creativity & Dedication

Daphne Zohar

Co-Founder & Chief Executive Officer

Ms. Daphne Zohar is the founder and Chief Executive Officer of PureTech (PRTC.L) and a member of the Board. Zohar created PureTech, assembling a leading team to help implement her vision for the Company, and attracting over $450M million to the Company and its business units. Zohar has been recognized as a top leader...

See More

Joi Ito

Chairman of the Board of Directors

Mr. Ito, the Director of the MIT Media Lab and the Chairman of PureTech’s Board of Directors, is a leading thinker and writer on innovation, global technology policy, and the role of the Internet in transforming society in substantial and positive ways. Mr. Ito sits on the boards of Sony Corporation, Knight Foundation, the John D. and Catherine T. MacArthur Foundation...

See More

Robert Langer, ScD

Co-Founder & Non-Executive Director, Scientific Advisory Board Member

Dr. Langer is a co-founder and Non-Executive Director at PureTech and sits on PureTech’s Scientific Advisory Board and the Boards of PureTech and Entrega. Dr. Langer is known for his groundbreaking discoveries in the fields of polymer chemistry, controlled drug delivery, and tissue engineering...

See More

Ben Shapiro, MD

Co-Founder & Non-Executive Director

Dr. Shapiro is a Co-founder and Non-Executive Director. He was previously Executive Vice President of Research for Merck. In this position he was responsible for all basic and preclinical research activities at Merck worldwide. Dr. Shapiro led the research program that resulted in FDA registration of approximately 25 drugs and vaccines. In addition to overseeing Merck internal research...

See More

Marjorie Scardino

Senior Independent Director

Dame Marjorie Scardino is the Senior Independent Director of PureTech’s Board of Directors. She served as Chief Executive of The Economist for 12 years and then from 1997 through 2012 was the Chief Executive of Pearson plc, the world's leading education company and the owner of Penguin Books and The Financial Times Group...

See More

Christopher Viehbacher

Independent Non-Executive Director

Mr Viehbacher is the Managing Partner of Gurnet Point Capital. He is also the Chairman of the Board of Directors of Boston Pharmaceuticals and of Vedanta as well as the Vice-Chair of Nuvelution. He is a member of the Board of Directors of Pronutria. Mr Viehbacher is a Trustee of Northeastern University and the Past-Chair of the CEO Roundtable on Cancer...

See More

Raju Kucherlapati, PhD

Independent Non-Executive Director, Scientific Advisory Board Member

Dr. Kuckerlapati is an Independent Non-Exeutive Director at PureTech and sits on PureTech’s Scientific Advisory Board. He was a founder and formerly a Board member of Abgenix (acquired by Amgen), and Millennium Pharmaceuticals (acquired by Takeda), and is currently the Paul C. Cabot Professor of Genetics and a Professor...

See More

John LaMattina, PhD

Independent Non-Executive Director

During Dr. LaMattina’s leadership tenure Pfizer discovered and/or developed a number of important new medicines including Tarceva, Chantix, Zoloft (PTSD), Selzentry and Lyrica along with a number of other medicines currently in late stage development for cancer, rheumatoid arthritis and pain. He is the author of numerous scientific publications and U.S. patents...

See More

Robert Horvitz, PhD

Board Advisor &
Scientific Advisory Board Chair

Dr. Horvitz is a Board Advisor and Scientific Advisory Board Chair of PureTech. He received the Nobel Prize in Physiology or Medicine and is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology, an Investigator of the Howard Hughes Medical Institute, Neurobiologist (Neurology)...

See More

Our Management

Joseph Bolen, PhD

Chief Scientific Officer

Joe Bolen is Chief Scientific Officer at PureTech where he works with the Company’s creation team to identify and pursue promising new technologies. Dr. Bolen has more than 30 years of industry and research experience and has been at the forefront of cancer and immunology research. He began his career at the NIH, where he contributed to the discovery of a class of proteins...

See More

Stephen Muniz

Chief Operating Officer

Mr. Muniz is the Chief Operating Officer and a member of PureTech’s Board of Directors. Prior to joining PureTech, Mr. Muniz was a Partner in the Corporate Department of Locke Lord LLP, where he practiced law for 10 years. Mr. Muniz’s practice at Locke Lord LLP focused on the representation of life science venture funds as well as their portfolio companies...

See More

David Steinberg

Chief Innovation Officer

Mr. Steinberg is the Chief Innovation Officer at PureTech. As a member of PureTech, Mr. Steinberg has served as founding CEO and board member of multiple programs, including Vedanta Biosciences, Entrega Biosciences, Vor Biopharma, and Commense Health. He also served as Chief Business Officer of Follica, Inc., and VP of Operations for Satori Pharmaceuticals...

See More

Eric Elenko, PhD

Chief of Research and Strategy

Dr. Elenko is the Chief of Research and Strategy at PureTech where he has co‑founded a number of companies for which he has acted as a board member and an interim member of the management team, including Akili Interactive Labs, Gelesis, Tal Medical, Karuna Pharmaceuticals and Sonde Health.  Prior to joining PureTech, Dr. Elenko was a consultant...

See More

Michael MacLean

Chief Financial Officer

Michael MacLean joined PureTech Health as Chief Financial Officer in 2015. Prior, he was Chief Financial Officer of Iron Mountain Inc.’s North American business, where overseeing $2.2bn of annual revenue and approximately $1bn of EBITDA. Previously, Mr. MacLean was Senior Vice President, Finance and Chief Accounting Officer at Biogen (NASDAQ: BIIB)...

See More

Our Team

Search for a PureTech Team member

UPDATED OCTOBER 2016